ArticleEye (London, England)2026
Eyelid ptosis and dermatochalasis in obese patients with obstructive sleep apnoea: A large-scale propensity score-matched analysis.
Article in Eye (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
objectivesWhile obstructive sleep apnoea (OSA) has been associated with various ocular manifestations, the relationship between OSA and eyelid disorders beyond floppy eyelid syndrome remains poorly characterised. This study investigated the association between OSA and eyelid ptosis and dermatochalasis in obese patients. SUBJECTS/
methodsA retrospective propensity score-matched cohort study was conducted using the TriNetX Research Network database (2015-2024). Obese patients with OSA confirmed by CPAP initiation (n = 315,223) were matched 1:1 with obese controls without OSA (n = 315,223) based on demographics and comorbidities. Primary outcomes included eyelid ptosis and dermatochalasis occurring after OSA diagnosis, analysed both as a composite outcome and as separate individual outcomes. Statistical analysis included risk ratios, odds ratios, number needed to harm (NNH), and time-to-event analysis with 95% confidence intervals.
resultsEyelid complications occurred in 7600 OSA patients (2.41%) versus 3890 controls (1.23%). OSA patients demonstrated significantly increased risk (risk ratio 1.95, 95% CI 1.88-2.03; odds ratio 1.98, 95% CI 1.90-2.06; NNH 119 patients, 95% CI 110-130; p < 0.0001). When analysed separately, ptosis occurred in 4760 OSA patients (1.51%) versus 2,112 controls (0.67%) with risk ratio 2.25 (95% CI 2.14-2.37, p < 0.0001). Dermatochalasis occurred in 4192 OSA patients (1.33%) versus 2207 controls (0.70%) with risk ratio 1.90 (95% CI 1.81-2.01, p < 0.0001).
conclusionOSA is independently associated with a nearly two-fold increased risk of eyelid ptosis and dermatochalasis in obese patients, beyond the known association with floppy eyelid syndrome. These findings support enhanced ophthalmologic surveillance in OSA patients and highlight the importance of recognising ocular manifestations in sleep disorder populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.